ADAM protease inhibition overcomes resistance of breast cancer stem-like cells to γδ T cell immunotherapy-Reference-Cited by-同舟云学术

ADAM protease inhibition overcomes resistance of breast cancer stem-like cells to γδ T cell immunotherapy

Published:2021-01 Issue: Volume:496 Page:156-168
ISSN:0304-3835
Container-title:Cancer Letters
language:en
Short-container-title:Cancer Letters

Author:

Dutta Indrani^ORCID,Dieters-Castator Dylan,Papatzimas James W.,Medina Anais^ORCID,Schueler Julia^ORCID,Derksen Darren J.,Lajoie Gilles,Postovit Lynne-Marie,Siegers Gabrielle M.^ORCID

Funder

Canadian Foundation for Innovation

Alberta Innovates Health Solutions

University of Alberta

Alberta Cancer Foundation

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference50 articles.

1. Cancer statistics;Siegel;CA A Cancer J. Clin.,2019

2. The role of breast cancer stem cells in metastasis and therapeutic implications;Velasco-Velazquez;Am. J. Pathol.,2011

3. CD44(+)/CD24(-) phenotype predicts a poor prognosis in triple-negative breast cancer;Wang;Oncol Lett,2017

4. Gammadelta T cells in cancer;Silva-Santos;Nat. Rev. Immunol.,2015

5. Six-of-the-best: unique contributions of gammadelta T cells to immunology;Vantourout;Nat. Rev. Immunol.,2013

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Synthetic and non-synthetic inhibition of ADAM10 and ADAM17 reduces inflammation and oxidative stress in LPS-induced acute kidney injury in male and female mice;European Journal of Pharmacology;2024-11

2. Unleashing the power of immune checkpoints: Post-translational modification of novel molecules and clinical applications;Cancer Letters;2024-04

3. Emerging mechanisms of the unfolded protein response in therapeutic resistance: from chemotherapy to Immunotherapy;Cell Communication and Signaling;2024-01-31

4. MHC class I chain-related genes B shedding modulates pancreatic tumor immunity via the activation of NKG2DLow T cells;2024-01-25

5. A fine-tuned machine learning model to predict survivals of breast cancer patients based on gamma-delta T cell markers;2023-09-29